Sumitovant Biopharma Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 319,300 shares at $7.67 ($2.4M) on 2020-03-24, disclosed to the SEC on 2020-03-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.67 | 211,200 | $1.6M | 66.3% |
| 2 | $7.60 | 108,100 | $822K | 33.7% |
| Total | $7.65 avg | 319,300 | $2.4M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-16 | $7.1M | — | Filing → |
| MYOV | BUY | 2021-09-08 | $3.4M | — | Filing → |
| MYOV | BUY | 2021-08-26 | $2.8M | — | Filing → |